As the incidence of cardiovascular disease (CVD) rises, it is becoming more important to assess risk factors for CVD, to reduce the incidence and mortality of the disease. Apolipoproteins are the main structural components of lipoproteins and have been linked to CVD risk. Randox can offer a full lipoprotein profile û including HDL, LDL, small dense LDL and apolipoproteins û for CVD risk assessment.
Apo A-I and Apo B, as well as other apolipoproteins and lipoproteins, are available from Randox as simple, highly accurate immunoturbidimetric tests for fully automated analysers in the routine clinical laboratory.
www.randox.com